FDA Rebukes Kim Kardashian for Morning-Sickness Drug Ad on Instagram

But pharma marketer Diclegis wins big anyway

The Food and Drug Administration has issued a warning letter informing Kim Kardashian's ad partner—the morning-sickness medication Diclegis—that her Instagram post promoting the drug was a no-no. Kardashian is pregnant with her and husband Kanye West's second child and came down with morning sickness in recent weeks.

Kardashian started taking Diclegis—evidently with great healing success—and has been pushing it on Instagram since July. She recently told an audience at the Cannes Lions International Festival of Creativity that she wouldn't do Instagram promos, but that was before the morning sickness (so cut her some slack).

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in